Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease

Genome Biology

Volumn 8, Issue 3, 2007, Pages

  Heinzen, Erin L ^a   Yoon, Woohyun ^a   Weale, Michael E ^a   Sen, Arjune ^b   Wood, Nicholas W ^b   Burke, James R ^c   Welsh Bohmer, Kathleen A ^c   Hulette, Christine M ^c   Sisodiya, Sanjay M ^a   Goldstein, David B ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ION CHANNEL; MESSENGER RNA;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE IDENTIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRINCIPAL COMPONENT ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA EXTRACTION; RNA TRANSCRIPTION; TEMPORAL LOBE EPILEPSY; UNINDEXED SEQUENCE; DNA MICROARRAY; GENETICS; POLYMERASE CHAIN REACTION;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; EPILEPSY, TEMPORAL LOBE; HUMANS; ION CHANNELS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION;

EID: 34250192963     PISSN: 14747596     EISSN: 1474760X     Source Type: Journal    
DOI: 10.1186/gb-2007-8-3-r32     Document Type: Article

References (46)

1. Syken J De-Medina T Munger K TID1, a human homolog of the Drosophila tumor suppressor l(2)tid, encodes two mitochondrial modulators of apoptosis with opposing functions. Proc Natl Acad Sci USA 1999, 96:8499-8504. 17545 10411904 10.1073/pnas.96.15.8499
2. Cartegni L Krainer AR Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002, 30:377-384. 10.1038/ng854 11925564
3. Hutton M Lendon CL Rizzu P Baker M Froelich S Houlden H Pickering-Brown S Chakraverty S Isaacs A Grover A Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998, 393:702-705. 10.1038/31508 9641683
4. Glatz DC Rujescu D Tang Y Berendt FJ Hartmann AM Faltraco F Rosenberg C Hulette C Jellinger K Hampel H The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease. J Neurochem 2006, 96:635-644. 10.1111/ j.1471-4159.2005.03552.x 16371011
5. Faustino NA Cooper TA Pre-mRNA splicing and human disease. Genes Dev 2003, 17:419-437. 10.1101/gad.1048803 12600935
6. Tate SK Depondt C Sisodiya SM Cavalleri GL Schorge S Soranzo N Thom M Sen A Shorvon SD Sander JW Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc Natl Acad Sci USA 2005, 102:5507-5512. 556232 15805193 10.1073/pnas.0407346102
7. Clark TA Sugnet CW Ares M Jr Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science 2002, 296:907-910. 10.1126/science.1069415 11988574
8. Fehlbaum P Guihal C Bracco L Cochet O A microarray configuration to quantify expression levels and relative abundance of splice variants. Nucleic Acids Res 2005, 33:e47. 1064144 15760843 10.1093/nar/gni047
9. Johnson JM Castle J Garrett-Engele P Kan Z Loerch PM Armour CD Santos R Schadt EE Stoughton R Shoemaker DD Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 2003, 302:2141-2144. 10.1126/science.1090100 14684825
10. Pan Q Saltzman AL Kim YK Misquitta C Shai O Maquat LE Frey BJ Blencowe BJ Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev 2006, 20:153-158. 1356107 16418482 10.1101/gad.1382806
11. Moulard B Picard F le Hellard S Agulhon C Weiland S Favre I Bertrand S Malafosse A Bertrand D Ion channel variation causes epilepsies. Brain Res Brain Res Rev 2001, 36:275-284. 10.1016/S0165-0173(01)00104-7 11690625
12. Hynd MR Scott HL Dodd PR Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004, 45:583-595. 10.1016/j.neuint.2004.03.007 15234100
13. Angulo E Noe V Casado V Mallol J Gomez-Isla T Lluis C Ferrer I Ciudad CJ Franco R Up-regulation of the Kv3.4 potassium channel subunit in early stages of Alzheimer's disease. J Neurochem 2004, 91:547-557. 10.1111/ j.1471-4159.2004.02771.x 15485486
14. Dewar D Chalmers DT Graham DI McCulloch J Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: An autoradiographic study of the hippocampus. Brain Res 1991, 553:58-64. 10.1016/0006-8993(91)90230-S 1933277
15. LaFerla FM Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 2002, 3:862-872. 10.1038/nrn960 12415294
16. Oddo S LaFerla FM The role of nicotinic acetylcholine receptors in Alzheimer's disease. J Physiol Paris 2006, 99:172-179. 10.1016/ j.jphysparis.2005.12.080 16448808
17. Wakabayashi K Narisawa-Saito M Iwakura Y Arai T Ikeda K Takahashi H Nawa H Phenotypic down-regulation of glutamate receptor subunit GluR1 in Alzheimer's disease. Neurobiol Aging 1999, 20:287-295. 10.1016/ S0197-4580(99)00035-4 10588576
18. Yasuda RP Ikonomovic MD Sheffield R Rubin RT Wolfe BB Armstrong DM Reduction of AMPA-selective glutamate receptor subunits in the entorhinal cortex of patients with Alzheimer's disease pathology: A biochemical study. Brain Res 1995, 678:161-167. 10.1016/ 0006-8993(95)00178-S 7542540
19. Seifert G Schroder W Hinterkeuser S Schumacher T Schramm J Steinhauser C Changes in flip/flop splicing of astroglial AMPA receptors in human temporal lobe epilepsy. Epilepsia 2002. 43(Suppl 5):162-167. 10.1046/ j.1528-1157.43.s.5.10.x 12121314
20. de Lanerolle NC Eid T von Campe G Kovacs I Spencer DD Brines M Glutamate receptor subunits GluR1 and GluR2/3 distribution shows reorganization in the human epileptogenic hippocampus. Eur J Neurosci 1998. 10:1687-1703. 10.1046/j.1460-9568.1998.00171.x 9751141
21. Tang B Li H Xia K Jiang H Pan Q Shen L Long Z Zhao G Cai F A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family. J Neurol Sci 2004, 221:31-34. 10.1016/j.jns.2004.03.001 15178210
22. Singh NA Westenskow P Charlier C Pappas C Leslie J Dillon J Anderson VE Sanguinetti MC Leppert MF BFNC Physician Consortium KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003, 126:2726-2737. 10.1093/brain/awg286 14534157
23. Singh NA Charlier C Stauffer D DuPont BR Leach RJ Melis R Ronen GM Bjerre I Quattlebaum T Murphy JV A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 1998, 18:25-29. 10.1038/ng0198-25 9425895
24. Lee WL Biervert C Hallmann K Tay A Dean JC Steinlein OK A KCNQ2 splice site mutation causing benign neonatal convulsions in a Scottish family. Neuropediatrics 2000, 31:9-12. 10.1055/s-2000-15290 10774989
25. de Haan GJ Pinto D Carton D Bader A Witte J Peters E van Erp G Vandereyken W Boezeman E Wapenaar MC A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years. Epilepsia 2006, 47:851-859. 10.1111/j.1528-1167.2006.00552.x 16686649
26. Claes LR Ceulemans B Audenaert D Deprez L Jansen A Hasaerts D Weckx S Claeys KG Del-Favero J Van Broeckhoven C De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 2004, 63:2155-2158. 15596769
27. Kananura C Haug K Sander T Runge U Gu W Hallmann K Rebstock J Heils A Steinlein OK A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 2002, 59:1137-1141. 10.1001/archneur.59.7.1137 12117362
28. Haug K Warnstedt M Alekov AK Sander T Ramirez A Poser B Maljevic S Hebeisen S Kubisch C Rebstock J Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 2003, 33:527-532. 10.1038/ng1121 12612585
29. Chioza B Wilkie H Nashef L Blower J McCormick D Sham P Asherson P Makoff AJ Association between the alpha(1a) calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology 2001, 56:1245-1246. 11342703
30. Chen Y Lu J Pan H Zhang Y Wu H Xu K Liu X Jiang Y Bao X Yao Z Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 2003, 54:239-243. 10.1002/ana.10607 12891677
31. Robbins TW Murphy ER Behavioural pharmacology: 40+ years of progress, with a focus on glutamate receptors and cognition. Trends Pharmacol Sci 2006, 27:141-148. 10.1016/j.tips.2006.01.009 16490260
32. Zamanillo D Sprengel R Hvalby O Jensen V Burnashev N Rozov A Kaiser KM Koster HJ Borchardt T Worley P Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 1999, 284:1805-1811. 10.1126/science.284.5421.1805 10364547
33. Schmitt WB Sprengel R Mack V Draft RW Seeburg PH Deacon RM Rawlins JN Bannerman DM Restoration of spatial working memory by genetic rescue of GluR-A-deficient mice. Nat Neurosci 2005, 8:270-272. 10.1038/nn1412 15723058
34. Schmitt WB Deacon RM Seeburg PH Rawlins JN Bannerman DM A within-subjects, within-task demonstration of intact spatial reference memory and impaired spatial working memory in glutamate receptor-A-deficient mice. J Neurosci 2003, 23:3953-3959. 12736365
35. Campion D Flaman JM Brice A Hannequin D Dubois B Martin C Moreau V Charbonnier F Didierjean O Tardieu S Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet 1995, 4:2373-2377. 10.1093/hmg/4.12.2373 8634712
36. Stutzmann GE Caccamo A LaFerla FM Parker I Dysregulated IP3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca2+ signals and altered membrane excitability. J Neurosci 2004, 24:508-513. 10.1523/ JNEUROSCI.4386-03.2004 14724250
37. Sommer B Keinanen K Verdoorn TA Wisden W Burnashev N Herb A Kohler M Takagi T Sakmann B Seeburg PH Flip and flop: A cell-specific functional switch in glutamate-operated channels of the CNS. Science 1990, 249:1580-1585. 10.1126/science.1699275 1699275
38. Seifert G Zhou M Dietrich D Schumacher TB Dybek A Weiser T Wienrich M Wilhelm D Steinhauser C Developmental regulation of AMPA-receptor properties in CA1 pyramidal neurons of rat hippocampus. Neuropharmacology 2000, 39:931-942. 10.1016/S0028-3908(99)00212-9 10727703
39. Seifert G Huttmann K Schramm J Steinhauser C Enhanced relative expression of glutamate receptor 1 flip AMPA receptor subunits in hippocampal astrocytes of epilepsy patients with Ammon's horn sclerosis. J Neurosci 2004, 24:1996-2003. 10.1523/JNEUROSCI.3904-03.2004 14985442
40. Pollard H Heron A Moreau J Ben-Ari Y Khrestchatisky M Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 1993, 57:545-554. 10.1016/ 0306-4522(93)90004-Y 8309523
41. Helton TD Horne WA Alternative splicing of the beta 4 subunit has alpha1 subunit subtype-specific effects on Ca2+ channel gating. J Neurosci 2002, 22:1573-1582. 11880487
42. Liu H De Waard M Scott VE Gurnett CA Lennon VA Campbell KP Identification of three subunits of the high affinity omega-conotoxin MVIIC-sensitive Ca2+ channel. J Biol Chem 1996, 271:13804-13810. 10.1074/ jbc.271.23.13804 8662888
43. Heinzen EL Yoon W Tate SK Sen A Wood NW Sisodiya SM Goldstein DB Nova2 interacts with a cis-acting polymorphism to influence the proportions of pharmacologically relevant splice variants of SCN1A. Am J Hum Genet 2007.
44. Tate SK Singh R Hung C Tai JJ Depondt C Cavalleri GL Sisodiya SM Goldstein DB Horng-Huei L A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose. Pharmacogenet Genomics 2006, 16:721-726. 17001291
45. Hulette C Welsh-Bohmer K Crain B Szymanski M Sinclaire N Roses A Rapid brain autopsy: The Brayn Alzheimer's Disease Research Center experience. Arch Pathol Lab Med 1997, 121:615-618. 9199629
46. Applied Biosystems. Guide to performing relative quantitation of gene expression using real-time quantitative PCR. http://docs.appliedbiosystems.com/pebiodocs/04371095.pdf